C. Zarnitsky

发表

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

P. Ravaud, X. Mariette, L. Chiche, 2012, Annals of the rheumatic diseases.

Treatment of Primary Sjgren Syndrome With Rituximab

X. Mariette, L. Chiche, J. Gottenberg, 2014, Annals of Internal Medicine.

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.

P. Ravaud, X. Mariette, J. Gottenberg, 2014, JAMA.

Treatment of primary Sjögren syndrome with rituximab: a randomized trial.

X. Mariette, L. Chiche, J. Gottenberg, 2014, Annals of internal medicine.

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Claire M. Riddell, R. Moots, D. Symmons, 2019, The Lancet Rheumatology.

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

E. Andrès, P. Dieudé, X. Mariette, 2020, Annals of the Rheumatic Diseases.

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

P. Garnero, J. Sany, D. Wendling, 2007, Annals of the rheumatic diseases.

Validation of the 2010-ACR/EULAR -classification criteria using newly EULAR-defined erosion for rheumatoid arthritis on the very early arthritis community-based (VErA) cohort.

J. Ménard, P. Boumier, P. Fardellone, 2015, Joint, bone, spine : revue du rhumatisme.

Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study

B. Pégourié, O. Decaux, X. Leleu, 2019, American journal of hematology.

Auto-Inflammatory Syndromes Revealing Hematological Disorders and Anakinra Efficacy in 2 Cases

C. Zarnitsky, D. Alcaix, A. Curie, 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.

D. Lipsker, A. Dupuy, M. Rybojad, 2020, Blood.

Severe Health‐Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient‐Reported Outcomes: Data From a Large Therapeutic Trial

X. Mariette, L. Chiche, J. Gottenberg, 2017, Arthritis care & research.

Microbiological diagnosis of suspected vertebral osteomyelitis with a focus on the yield of percutaneous needle biopsy: a 10-year cohort study

G. Avenel, C. Zarnitsky, O. Vittecoq, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

A. Vissink, X. Mariette, L. Chiche, 2015, Rheumatology.

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

P. Ravaud, X. Mariette, J. Gottenberg, 2016, JAMA.

S. Leyvraz, Sung-Soo Yoon, C. Langer, 2014 .

Analgesic effect of sacroplasty in osteoporotic sacral fractures: a study of six cases.

C. Zarnitsky, A. Trouvin, T. Somon, 2012, Joint, bone, spine : revue du rhumatisme.

S. Leyvraz, Sung-Soo Yoon, C. Langer, 2015, Haematologica.

Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial

M. Mohty, P. Moreau, H. Avet-Loiseau, 2019, British journal of haematology.

Cervical spinal calcinosis in a patient with systemic sclerosis.

C. Zarnitsky, D. Weinstein, T. Somon, 2013, Diagnostic and interventional imaging.

Musculoskeletal imaging Cervical spinal calcinosis in a patient with systemic sclerosis

C. Zarnitsky, D. Weinstein, T. Somon, 2013 .

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.

M. Dougados, X. Mariette, F. Berenbaum, 2009, Rheumatology.

Thromboangiitis obliterans with arthralgia, diarrhea and nodules as the first symptoms.

H. Lévesque, C. Zarnitsky, P. Bravard, 1997, Revue du rhumatisme.

Efficacité des anti-TNF chez les patients atteints de spondyloarthropathie en l’absence de signes à l’imagerie

X. L. Loët, X. le Loët, J. Dacher, 2013 .

Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging sign.

X. le Loët, J. Dacher, C. Zarnitsky, 2013, Joint, bone, spine : revue du rhumatisme.

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients

P. Ravaud, X. Mariette, A. Saraux, 2013, Arthritis care & research.

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study.

O. Decaux, P. Moreau, H. Avet-Loiseau, 2023, Haematologica.

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?

P. Dieudé, X. Mariette, L. Chiche, 2015, PloS one.

Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community‐based inception cohort

J. Ménard, P. Boumier, P. Fardellone, 2010, Arthritis care & research.

[Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases].

C. Zarnitsky, N. Litrowski, C. Zarnitsky, 2019, La Revue de medecine interne.

IgG1 Subclass Restriction and Biochemical Peculiarities of Monoclonal Immunoglobulins in Scleromyxedema.

A. Mékinian, C. Zarnitsky, P. Modiano, 2021, Clinical laboratory.

Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.

X. Mariette, L. Chiche, J. Gottenberg, 2012 .

Necrotizing autoimmune myopathy associated with POEMS syndrome report.

C. Boulard, C. Zarnitsky, F. Marguet, 2018, QJM : monthly journal of the Association of Physicians.